The majority of studies on Synpo2 in the context of invasive cancer cell migration use PC3 prostate cancer cells and ectopic expression of the Synpo2As isoform, a 698-residue isoform also referred to as ΔN-MYO1 [17]. This evidence concerns the gene SYNPO2 and prostate carcinoma.